Pharvaris expects pivotal HAE study data in third quarter 2026
Go back to Pharvaris expects pivotal HAE study data in third quarter 2026| (NASDAQ: PHVS) | Delayed: 33.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.19 | 52 Week High | $ | |||
| Open | $33.19 | 52 Week Low | $ | |||
| Day High | $33.19 | P/E | N/A | |||
| Day Low | $33.19 | EPS | $ | |||
| Volume | 3 | |||||

